trending Market Intelligence /marketintelligence/en/news-insights/trending/HhbMzl6IKAp5be6Ebk9Wqg2 content esgSubNav
In This List

Merrimack names chief medical officer

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Merrimack names chief medical officer

Sergio Santillana will become Merrimack Pharmaceuticals Inc.'s chief medical officer on June 12.

Santillana is the former chief medical officer at ARIAD Pharmaceuticals.